{"id":325248,"date":"2026-10-23T14:07:49","date_gmt":"2026-10-23T08:37:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=325248"},"modified":"2026-10-23T14:07:49","modified_gmt":"2026-10-23T08:37:49","slug":"specialty-branded-generics-global-generics-and-injectables-and-cardiac-therapy-leader-stocks-roadmap-cornerstone-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/specialty-branded-generics-global-generics-and-injectables-and-cardiac-therapy-leader-stocks-roadmap-cornerstone-list\/","title":{"rendered":"3 Specialty Branded Generics, Global Generics and Injectables and Cardiac Therapy Leader Stocks With a Strong Future Roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals"},"content":{"rendered":"

Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals: ROE of 9.2% to 25.5% and FY22 to FY26 revenue CAGR of 9.5% to 12.9%. Prices as of 22 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three branded generic and global formulation stocks to watch are Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals. Their return on equity ranges from 9.2% to 25.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.5% to 12.9%. Torrent Pharmaceuticals has the highest return on equity at 25.5%, while Ajanta Pharma has the fastest revenue growth at 12.9% a year. Prices are based on the 22 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Branded generic and global formulation stocks let investors follow pharmaceutical companies that sell finished medicines in many markets. Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals cover specialty branded generics, global generics and injectables, and a leader in cardiac and central nervous system therapies.<\/p>\n

This list covers three branded generic and global formulation stocks with complete current figures: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals. Every figure comes from the latest reported financials and the 22 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n